Reports for HOFFMANN-LA ROCHE LIMITED
Company Name
HOFFMANN-LA ROCHE LIMITED
Totals |
||
Shortage reports |
21 |
|
| Actual shortage: | 1 (5%) | |
| Anticipated shortage: | 1 (5%) | |
| Avoided shortage: | 7 (33%) | |
| Resolved: | 12 (57%) | |
Discontinuation Reports |
16 |
|
| To be discontinued: | 6 (38%) | |
| Discontinued: | 10 (63%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (11%) |
|
Overdue reports |
1 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACCUTANE ROCHE | 10MG | CAPSULE | Resolved | 2024-06-07 | 2024-09-18 | 229980 |
| ACCUTANE ROCHE | 40MG | CAPSULE | Actual shortage | 2024-06-07 | 2024-12-02 | 229983 |
| ACTEMRA | 80MG | SOLUTION | Avoided shortage | 2021-08-20 | 2022-07-20 | 144365 |
| ACTEMRA | 200MG | SOLUTION | Resolved | 2021-08-23 | 2021-12-10 | 144437 |
| ACTEMRA | 200MG | SOLUTION | Avoided shortage | 2022-02-17 | 2022-07-20 | 155146 |
| ACTEMRA | 400MG | SOLUTION | Avoided shortage | 2021-08-23 | 2022-07-20 | 144440 |
| ACTEMRA | 162MG | SOLUTION | Resolved | 2021-07-13 | 2021-11-26 | 142457 |
| ACTEMRA | 162MG | SOLUTION | Resolved | 2022-03-31 | 2022-12-07 | 157625 |
| ACTEMRA | 162MG | SOLUTION | Avoided shortage | 2021-07-12 | 2021-11-25 | 142322 |
| ACTEMRA | 162MG | SOLUTION | Resolved | 2022-03-04 | 2022-12-07 | 156092 |
| ACTIVASE RT-PA | 100ML 100MG | POWDER FOR SOLUTION LIQUID | Anticipated shortage | 2024-11-22 | 2024-11-22 | 243681 |
| CATHFLO | 2MG | POWDER FOR SOLUTION | Avoided shortage | 2024-05-15 | 2024-09-30 | 227997 |
| CELLCEPT | 250MG | CAPSULE | Resolved | 2024-09-17 | 2024-11-13 | 237837 |
| CELLCEPT | 500MG | TABLET | Resolved | 2024-01-24 | 2024-03-13 | 217099 |
| ENSPRYNG | 120MG | SOLUTION | Avoided shortage | 2024-05-06 | 2024-05-14 | 227132 |
| ESBRIET | 267MG | TABLET | Resolved | 2021-04-20 | 2021-06-01 | 137715 |
| RITUXAN SC | 1400MG | SOLUTION | Resolved | 2024-11-19 | 2024-12-04 | 243448 |
| TAMIFLU | 75MG | CAPSULE | Resolved | 2022-10-27 | 2022-12-15 | 172732 |
| TAMIFLU | 6MG | POWDER FOR SUSPENSION | Avoided shortage | 2018-02-08 | 2018-02-28 | 39146 |
| TAMIFLU | 6MG | POWDER FOR SUSPENSION | Resolved | 2020-02-13 | 2020-04-21 | 105912 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ESBRIET | 267MG | CAPSULE | Discontinued | 2023-08-03 | 2023-08-03 | 200961 |
| ESBRIET | 267MG | CAPSULE | Discontinued | 2023-08-03 | 2023-08-03 | 200964 |
| ESBRIET | 267MG | TABLET | Discontinued | 2023-08-03 | 2023-08-03 | 200955 |
| FUZEON | 108MG | POWDER FOR SOLUTION | To be discontinued | 2024-10-07 | 2024-10-07 | 239548 |
| GAVRETO | 100MG | CAPSULE | To be discontinued | 2024-11-06 | 2024-11-06 | 242142 |
| INVIRASE | 500MG | TABLET | Discontinued | 2021-01-20 | 2021-01-20 | 132101 |
| INVIRASE - CAP 200MG | 200MG | CAPSULE | To be discontinued | 2018-06-28 | 2018-06-28 | 53093 |
| LECTOPAM TAB 3MG | 3MG | TABLET | Discontinued | 2017-08-29 | 2018-04-03 | 20572 |
| LECTOPAM TAB 6MG | 6MG | TABLET | Discontinued | 2017-08-28 | 2018-04-03 | 20448 |
| NUTROPIN AQ NUSPIN 10 | 10MG | SOLUTION | To be discontinued | 2024-07-03 | 2024-07-08 | 232079 |
| NUTROPIN AQ NUSPIN 20 | 20MG | SOLUTION | To be discontinued | 2024-07-03 | 2024-07-08 | 232086 |
| NUTROPIN AQ NUSPIN 5 | 5MG | SOLUTION | To be discontinued | 2024-07-03 | 2024-07-08 | 232071 |
| NUTROPIN AQ PEN CARTRIDGE | 10MG | SOLUTION | Discontinued | 2017-06-30 | 2018-01-04 | 14451 |
| TARCEVA | 25MG | TABLET | Discontinued | 2024-07-19 | 2024-10-02 | 233440 |
| TARCEVA | 100MG | TABLET | Discontinued | 2024-07-19 | 2024-10-02 | 233443 |
| TARCEVA | 150MG | TABLET | Discontinued | 2024-07-19 | 2024-10-02 | 233446 |
Showing 1 to 16 of 16